Saturday, December 18, 2021 5:36:55 PM
I'm well versed on Dr. Koos, having invested in his companies for ten years. If you don't believe me, see my posting history on Ihub. I was always an enthusiastic advocate of the science and his tickers, first with his failed company BMSN, and then RGBP and RGBPP.
Let's look at evidence.
The problem with Koos is that he has never delivered. Sure a few traders have hit the jackpot, but the pattern has been one of continual disappointment with long term investors.
A manager needs to step up and show his investors that a company is more than an OTC ponzi scheme. I haven't seen evidence of that. I haven't seen evidence that mRNA vaccines are the wave of the future. I haven't seen evidence that Regen holds a unique position on research and development of immune checkpoint inhibitors.
Lastly, with my long experience with Koos, I haven't seen evidence that this old dog is learning a new trick unless it's out of desperation regarding debt or obligations. In other words, Koos has had to pause his dissolute, ill-earned lifestyle for a while to shore up his market cap to finally pay off some debt.
Stick around for a few years and see if anything changes. I'll be delighted if it does. Honestly. Good luck to you.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM